Designing A Marketing Model for Pharmaceutical Products in Iraq
Keywords:
Marketing - Management - Pharmaceutical ProductsAbstract
At the present time The Marketing in pharmaceutical products is considered as one of the important issues in marketing management; considering the importance of this issue, this research seeks to find a marketing model for pharmaceutical products in iraq. The research is in terms of the fundamental goal and in terms of the descriptive method, the analysis is obtained by using the model experts' interviews. In this research, firstly, the issue has been examined by using expert interviews, and finally, the final model of the research has been drawn. In this research, the analysis of the market context was first examined and analyzed. In fact, this problem is one of the basic concepts in the field of the final model, which includes four dimensions of customer analysis, industry analysis, environmental analysis, and analysis of colleagues. It shows the needs of the customers and the characteristics of the industry, and the environment actually shows the necessary environment for the marketing model. On the other hand, the analysis of colleagues makes the situation of the competitors to be considered, and this helps in improving marketing.
Downloads
Metrics
References
Aghazadeh, h., & estiri, m, (2007), investigating the factors affecting the competitiveness of firms in iran, economic research, 6(3), 37-52. (in persian)
Behzad pagheh and sanjay eksambekar (2017). Analysis of marketing strategy in pharmaceutical industry.
Biswas k, ferdousy uk. Influence of pharmaceutical marketing on prescription behavior of physicians: a cross-sectional study in bangladesh. J account mark 2016; 5(2): 160. Doi: 10.4172/2168-9601.1000160.
Enar ruiz-condejaap e. Wieringapeter s. H. Leeflang (2014). Competitive diffusion of new prescription drugs: the role of pharmaceutical marketing investment. Technological forecasting and social changeoctober 2014volume 88pages 49-63
Gabriela masárováľubica štefánikovámartina rypáková (2015). The necessity of obtaining information through marketing research in the field of pharmaceutical companies on the slovak market. Procedia economics and finance2015volume 23pages 1480-1484
Jones, e., brown, s.p., zoltners, a.a. and weitz, b.a. (2005) ‘the changing environment of selling and sales management’, journal of personal selling & sales management, vol. 25, 2, pp.105–111.
Lea prevel katsanis (2015). Global issues in pharmaceutical marketing. Publisher: routledge; 1st edition (july 16, 2015)
Mcfadden dw, calvario e, graves c. The devil is in the details: the pharmaceutical industry's use of gifts to physicians as marketing strategy. J surg res 2007; 140(1): 1-5. Doi: 10.1016/j.jss. 2006. 10.010.
Neves, m.f., castro, l.c. and consoli, m.a. (2010) marketing methods to improve company strategy, routledge, london
Salmasi sh, ming lch, khan tm. Interaction and medical inducement between pharmaceutical representatives and physicians: a meta-synthesis. J pharm policy pract 2016; 9: 37. Doi: 10.1186/ s40545-016-0089-z.
Schuiling, i. & moss, g. (2004). A brand logic for pharma? A possible strategy based on fmcg experience. International journal of medical marketing, 4(1), 55-62.
Scott weintraub, r.j. lewis, joanne mchugh, roger zan, brad sitler (2015). Results: the future of pharmaceutical and healthcare marketing. Publisher: advantage media group (august 25, 2015)
Sepehvand, r., & shariatnejad, a. (2015). Investigating the impact of competitive intelligence on competitive power and industrial competition in lorestan province, industrial management, 13 (36), 173-198. (in persian)
Siniša tomićanita filipović sučićadrijana ilić martinac (2010). Granting marketing authorisation for medicines in south east european countries: the point of view of the authority. Regulatory toxicology and pharmacologyjuly–august 2010volume 57, issues 2–3pages 325-332
Smolynets,’ i.b., gutyj, b.v., khariv, і.і., petryshak, o.y., lytvyn, r.i. (2016). Pharmaceutical marketing: objectives and types. Scientific messenger lnuvmbt named after s.z. gzhytskyj, 18, 2(69), 151–154.
Smolynets,’ i.b., gutyj, b.v., khariv, і.і., petryshak, o.y., lytvyn, r.i. (2016). Pharmaceutical marketing: objectives and types. Scientific messenger lnuvmbt named after s.z. gzhytskyj, 18, 2(69), 151–154.
Syndicate of iraqi pharmacists. [pharmacy schools' statistics (arabic)] [internet]. 2017 [accessed 2017 june 14]. Available from: http://www.iraqipharm.com
Ziai, m. & beer, b. (1990). Making business sense of science with rational during design. Pharmaceutical executive,
Abel Demerew Hailu, Birhanu Demeke Workneh & Mesfin Haile Kahissay (2021). Influence Of Pharmaceutical Marketing Mix Strategies On Physicians’ Prescribing Behaviors In Public And Private Hospitals, Dessie, Ethiopia: A Mixed Study Design. BMC Public Health Volume 21, Article Number: 65 (2021)
Agbogbo F. Current Perspectives On Biosimilar. Journal Of Industrial Microbiology & Biotechnology 2019; 46(9-10): 1297-311.
Aghazadeh, H., & Estiri, M, (2007), Investigating The Factors Affecting The Competitiveness
Akimova, I. (2000). Development Of Market Orientation And Competitiveness Of Ukrainian
Ali Asadi (2019). The Ultimate Marketing Guide For Medical Practices (Second Edition) Audible Logo Audible Audiobook – Unabridged. Publisher :Asadi Business Consulting, Inc
Alkhateeb, F., Khanfar, N., & Clauson, K. (2009). Characteristics Of Physicians Who Frequently See Pharmaceutical Sale Representative. Journal Of Hospital Marketing And Public Relation,19 (1), 2-14.
American Marketing Association. Available From URL: Https://Www.Ama.Org/Aboutama/Pages/Definitio N-Of-Marketing.Aspx. Last Access: Jul 5, 2013.
And Attitudes Of Medical Sales Representatives (Msrs) And Prescribers Regarding Pharmaceutical
Bamel, N., & Bamel, U. (2020). Big Data Analytics Based Enablers Of Supply Chain Capabilities And Firm Competitiveness: A Fuzzy-TISM Approach. Journal Of Enterprise Information Management.
Bansal RK, Das S. Unethical Relationship Between Doctors And Drugs Companies. JIAFM 2005; 27(1): 40-2.
Barney, J., Wright, M., & Ketchen Jr, D. J. (2001). The Resource-Based View Of The Firm: Ten
Behzad Pagheh And Sanjay Eksambekar (2017). Analysis Of Marketing Strategy In Pharmaceutical Industry.
Biswas K, Ferdousy UK. Influence Of Pharmaceutical Marketing On Prescription Behavior Of Physicians: A Cross-Sectional Study In Bangladesh. J Account Mark 2016; 5(2): 160. Doi: 10.4172/2168-9601.1000160.
Blackett, T. & Harrison, T. (2001). Branding Medicine: Use And Future Potential Of Branding In Pharmaceutical Markets. International Journal Of Medical Marketing, 2(1), 33-49.
Brent L. Rollins , Matthew Perri (2013). Pharmaceutical Marketing. Publisher : Jones & Bartlett Learning; 1st Edition (February 26, 2013)
Chesbrough H & Rosenbloom RS. The Role Of The Business Model In Capturing Value From Innovation: Evidence From Xerox Corporation’s Technology Spinoff Companies. Industrial And Corporate Change 2002; 11(3): 529-55.
Chris Harrison (2019). Marketing Medicine: A Shot In The Arm For Business In Africa. Publisher : Chris Harrison (May 18, 2019)
Dess And Lumpkin (2003) Strategic Management; Mc Graw-Hill.
Directoroate Of Technichal Affairs. Pharmaceutical Factories Statistics [Internet]. 2017 [Updated 2017 June 10]. Available From: Http:// Www.Tecmoh.Com/Pharmacy.Php
Dogramatizis, D. (2002). Pharmaceutical Marketing: A Practical Guide. Florida: CRC Press.
Enar Ruiz-Condejaap E. Wieringapeter S. H. Leeflang(2014). Competitive Diffusion Of New Prescription Drugs: The Role Of Pharmaceutical Marketing Investment. Technological Forecasting And Social Changeoctober 2014Volume 88Pages 49-63
Eugene Mick Kolassa, James Greg Perkins, Bruce R Siecker (2002). Pharmaceutical Marketing: Principles, Environment, And Practice. Publisher : CRC Press; 1st Edition (March 12, 2002)
Fadlallah R, Alkhaled L, Brax H, Nasser M, Rajabbik MH, Nass H, Et Al. Extent Of Physicianpharmaceutical
Feizpour, F., & Emami M. (2016). Competition And Its Impact On Increasing Social Welfare,
Firms. European Journal Of Marketing.
Gabriela Masárováľubica Štefánikovámartina Rypáková (2015). The Necessity Of Obtaining Information Through Marketing Research In The Field Of Pharmaceutical Companies On The Slovak Market. Procedia Economics And Finance2015Volume 23Pages 1480-1484
Goodarzi M & Goodarzi M. Review Of Commercialization Process Of Biopharmaceuticals: Lessons For Iran’s Drug Industry. Rahyaft 2014; 24(57): 35-53[Article In Persian].
Goodarzi M, Goodarzi M, Sheikhi M & Shabani M. Commercialization Process Of Biopharmaceuticals Development. International Journal Of Innovation, Management And Technology 2017; 8(4): 289-92.
Hamel G. Leading The Revolution. Boston: Harvard Business School Press; 2000: 50-2
